APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Women's Health

This report focuses on pharmaceutical products for female-related diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report focuses on pharmaceutical products for female-related diseases.

Selected research

Market Outlook & Growth Opportunities

Global Women's Health Market Outlook and Growth Opportunities 2026

Report ID 174047760429 December 2025192 pages

Choose your research edition.

Industry ResearchWomen's Health Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Women's Health Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Women's Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Women's Health Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Women's Health Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

This report focuses on pharmaceutical products for female-related diseases.

The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.

This report provides an overview of the global Women's Health market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Women's Health and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Women's Health revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Women's Health market.

Women's Health Segment by Company

Amgen

Bayer

Merck KGaA

Merck & Co

Ferring

Eli Lilly

Pfizer

AbbVie

Abbott

Theramex

Livzon Pharmaceutical Group

Foundation Consumer Healthcare

Zhejiang Xianju Pharmaceutical

Zizhu Pharmaceutical

Qianjin Pharmaceutical

Women's Health Segment by Type

Hormone Therapy

Nonhormonal Therapy

Women's Health Segment by Application

Climacteric

Postmenopausal Osteoporosis

Contraceptive Pill

Infertility

Others

Women's Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Women's Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Women's Health key companies, revenue, market share, and recent developments.

3. To split the Women's Health breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Women's Health market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Women's Health significant trends, drivers, influence factors in global and regions.

6. To analyze Women's Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Women's Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Women's Health industry.

Chapter 3: Detailed analysis of Women's Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Women's Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Women's Health in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Women's Health Industry Trends Table 2. Women's Health Industry Drivers Table 3. Women's Health Industry Opportunities and Challenges Table 4. Women's Health Industry Restraints Table 5. Global Women's Health Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Women's Health Revenue Share by Company (2021-2026) Table 7. Global Women's Health Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Women's Health Key Company Manufacturing Base & Headquarters Table 9. Global Women's Health Company, Product Type & Application Table 10. Global Women's Health Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Women's Health by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hormone Therapy Table 15. Significant Companies of Nonhormonal Therapy Table 16. Global Women's Health Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Women's Health Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Women's Health Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Women's Health Sales Value Share by Type (2021-2026) Table 20. Global Women's Health Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Climacteric Table 22. Significant Companies of Postmenopausal Osteoporosis Table 23. Significant Companies of Contraceptive Pill Table 24. Significant Companies of Infertility Table 25. Significant Companies of Others Table 26. Global Women's Health Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Women's Health Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Women's Health Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Women's Health Sales Value Share by Application (2021-2026) Table 30. Global Women's Health Sales Value Share by Application (2027-2032) Table 31. Global Women's Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Women's Health Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Women's Health Sales Value Share by Region (2021-2026) Table 34. Global Women's Health Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Women's Health Sales Value Share by Region (2027-2032) Table 36. Global Women's Health Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Women's Health Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Women's Health Sales Value Market Share by Country (2021-2026) Table 39. Global Women's Health Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Women's Health Sales Value Market Share by Country (2027-2032) Table 41. Amgen Company Information Table 42. Amgen Business Overview Table 43. Amgen Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Amgen Women's Health Product Portfolio Table 45. Amgen Recent Development Table 46. Bayer Company Information Table 47. Bayer Business Overview Table 48. Bayer Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Bayer Women's Health Product Portfolio Table 50. Bayer Recent Development Table 51. Merck KGaA Company Information Table 52. Merck KGaA Business Overview Table 53. Merck KGaA Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Merck KGaA Women's Health Product Portfolio Table 55. Merck KGaA Recent Development Table 56. Merck & Co Company Information Table 57. Merck & Co Business Overview Table 58. Merck & Co Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Merck & Co Women's Health Product Portfolio Table 60. Merck & Co Recent Development Table 61. Ferring Company Information Table 62. Ferring Business Overview Table 63. Ferring Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Ferring Women's Health Product Portfolio Table 65. Ferring Recent Development Table 66. Eli Lilly Company Information Table 67. Eli Lilly Business Overview Table 68. Eli Lilly Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eli Lilly Women's Health Product Portfolio Table 70. Eli Lilly Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Women's Health Product Portfolio Table 75. Pfizer Recent Development Table 76. AbbVie Company Information Table 77. AbbVie Business Overview Table 78. AbbVie Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. AbbVie Women's Health Product Portfolio Table 80. AbbVie Recent Development Table 81. Abbott Company Information Table 82. Abbott Business Overview Table 83. Abbott Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Abbott Women's Health Product Portfolio Table 85. Abbott Recent Development Table 86. Theramex Company Information Table 87. Theramex Business Overview Table 88. Theramex Women's Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Theramex Women's Health Product Portfolio Table 90. Theramex Recent Development Table 91. Livzon Pharmaceutical Group Company Information Table 92. Livzon Pharmaceutical Group Business Overview Table 93. Livzon Pharmaceutical Group Women's Health Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 94. Livzon Pharmaceutical Group Women's Health Product Portfolio Table 95. Livzon Pharmaceutical Group Recent Development Table 96. Foundation Consumer Healthcare Company Information Table 97. Foundation Consumer Healthcare Business Overview Table 98. Foundation Consumer Healthcare Women's Health Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 99. Foundation Consumer Healthcare Women's Health Product Portfolio Table 100. Foundation Consumer Healthcare Recent Development Table 101. Zhejiang Xianju Pharmaceutical Company Information Table 102. Zhejiang Xianju Pharmaceutical Business Overview Table 103. Zhejiang Xianju Pharmaceutical Women's Health Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 104. Zhejiang Xianju Pharmaceutical Women's Health Product Portfolio Table 105. Zhejiang Xianju Pharmaceutical Recent Development Table 106. Zizhu Pharmaceutical Company Information Table 107. Zizhu Pharmaceutical Business Overview Table 108. Zizhu Pharmaceutical Women's Health Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 109. Zizhu Pharmaceutical Women's Health Product Portfolio Table 110. Zizhu Pharmaceutical Recent Development Table 111. Qianjin Pharmaceutical Company Information Table 112. Qianjin Pharmaceutical Business Overview Table 113. Qianjin Pharmaceutical Women's Health Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 114. Qianjin Pharmaceutical Women's Health Product Portfolio Table 115. Qianjin Pharmaceutical Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Women's Health Product Image Figure 2. Global Women's Health Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Women's Health Market Size (2021-2032) & (US$ Million) Figure 4. Global Women's Health Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hormone Therapy Image Figure 8. Nonhormonal Therapy Image Figure 9. Global Women's Health Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Women's Health Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Women's Health Sales Value Share by Type (2021-2032) Figure 12. Climacteric Image Figure 13. Postmenopausal Osteoporosis Image Figure 14. Contraceptive Pill Image Figure 15. Infertility Image Figure 16. Others Image Figure 17. Global Women's Health Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Women's Health Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Women's Health Sales Value Share by Application (2021-2032) Figure 20. Global Women's Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Women's Health Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Women's Health Sales Value (2021-2032) & (US$ Million) Figure 23. North America Women's Health Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Women's Health Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Women's Health Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Women's Health Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Women's Health Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Women's Health Sales Value (2021-2032) & (US$ Million) Figure 29. South America Women's Health Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Women's Health Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Women's Health Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Women's Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Women's Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Women's Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Hormone Therapy
  • Nonhormonal Therapy
Applications
  • Climacteric
  • Postmenopausal Osteoporosis
  • Contraceptive Pill
  • Infertility
  • Others
Companies covered
  • Amgen
  • Bayer
  • Merck KGaA
  • Merck & Co
  • Ferring
  • Eli Lilly
  • Pfizer
  • AbbVie
  • Abbott
  • Theramex
  • Livzon Pharmaceutical Group
  • Foundation Consumer Healthcare
  • Zhejiang Xianju Pharmaceutical
  • Zizhu Pharmaceutical
  • Qianjin Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Women's Health Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Women's Health Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Women's Health Market Dynamics
  1. 2.1 Women's Health Industry Trends
  2. 2.2 Women's Health Industry Drivers
  3. 2.3 Women's Health Industry Opportunities and Challenges
  4. 2.4 Women's Health Industry Restraints
3 Women's Health Market by Company
  1. 3.1 Global Women's Health Company Revenue Ranking in 2025
  2. 3.2 Global Women's Health Revenue by Company (2021-2026)
  3. 3.3 Global Women's Health Company Ranking (2024-2026)
  4. 3.4 Global Women's Health Company Manufacturing Base and Headquarters
  5. 3.5 Global Women's Health Company Product Type and Application
  6. 3.6 Global Women's Health Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Women's Health Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Women's Health Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Women's Health Market by Type
  1. 4.1 Women's Health Type Introduction
  2. 4.1.1 Hormone Therapy
  3. 4.1.2 Nonhormonal Therapy
  4. 4.2 Global Women's Health Sales Value by Type
  5. 4.2.1 Global Women's Health Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Women's Health Sales Value by Type (2021-2032)
  7. 4.2.3 Global Women's Health Sales Value Share by Type (2021-2032)
5 Women's Health Market by Application
  1. 5.1 Women's Health Application Introduction
  2. 5.1.1 Climacteric
  3. 5.1.2 Postmenopausal Osteoporosis
  4. 5.1.3 Contraceptive Pill
  5. 5.1.4 Infertility
  6. 5.1.5 Others
  7. 5.2 Global Women's Health Sales Value by Application
  8. 5.2.1 Global Women's Health Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Women's Health Sales Value by Application (2021-2032)
  10. 5.2.3 Global Women's Health Sales Value Share by Application (2021-2032)
6 Women's Health Regional Value Analysis
  1. 6.1 Global Women's Health Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Women's Health Sales Value by Region (2021-2032)
  3. 6.2.1 Global Women's Health Sales Value by Region: 2021-2026
  4. 6.2.2 Global Women's Health Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Women's Health Sales Value (2021-2032)
  7. 6.3.2 North America Women's Health Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Women's Health Sales Value (2021-2032)
  10. 6.4.2 Europe Women's Health Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Women's Health Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Women's Health Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Women's Health Sales Value (2021-2032)
  16. 6.6.2 South America Women's Health Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Women's Health Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Women's Health Sales Value Share by Country, 2025 VS 2032
7 Women's Health Country-level Value Analysis
  1. 7.1 Global Women's Health Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Women's Health Sales Value by Country (2021-2032)
  3. 7.2.1 Global Women's Health Sales Value by Country (2021-2026)
  4. 7.2.2 Global Women's Health Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Women's Health Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Women's Health Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Women's Health Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Women's Health Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Women's Health Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Women's Health Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Women's Health Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Women's Health Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Women's Health Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Women's Health Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Women's Health Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Women's Health Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Women's Health Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Women's Health Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Women's Health Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Women's Health Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Women's Health Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Women's Health Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Women's Health Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Women's Health Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Women's Health Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Women's Health Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Women's Health Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Women's Health Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Women's Health Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Women's Health Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Women's Health Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Women's Health Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Women's Health Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Women's Health Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Women's Health Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Women's Health Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Women's Health Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Women's Health Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Women's Health Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Women's Health Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Women's Health Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Women's Health Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Women's Health Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Women's Health Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Women's Health Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Women's Health Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Women's Health Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Women's Health Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Women's Health Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Women's Health Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Women's Health Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Women's Health Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Women's Health Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Women's Health Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Women's Health Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Women's Health Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Women's Health Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Women's Health Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Women's Health Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Women's Health Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Women's Health Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Women's Health Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Women's Health Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Women's Health Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Women's Health Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Women's Health Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Women's Health Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Women's Health Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Women's Health Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Women's Health Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Women's Health Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Women's Health Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Women's Health Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Women's Health Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Women's Health Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Women's Health Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Women's Health Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Women's Health Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Women's Health Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Women's Health Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Women's Health Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Women's Health Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Women's Health Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Women's Health Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Women's Health Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Women's Health Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Women's Health Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Women's Health Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amgen
  2. 8.1.1 Amgen Company Information
  3. 8.1.2 Amgen Business Overview
  4. 8.1.3 Amgen Women's Health Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amgen Women's Health Product Portfolio
  6. 8.1.5 Amgen Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Women's Health Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Women's Health Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Women's Health Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Women's Health Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 Merck & Co
  20. 8.4.1 Merck & Co Company Information
  21. 8.4.2 Merck & Co Business Overview
  22. 8.4.3 Merck & Co Women's Health Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co Women's Health Product Portfolio
  24. 8.4.5 Merck & Co Recent Developments
  25. 8.5 Ferring
  26. 8.5.1 Ferring Company Information
  27. 8.5.2 Ferring Business Overview
  28. 8.5.3 Ferring Women's Health Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ferring Women's Health Product Portfolio
  30. 8.5.5 Ferring Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Women's Health Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Women's Health Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Women's Health Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Women's Health Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie Women's Health Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie Women's Health Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 Abbott
  50. 8.9.1 Abbott Company Information
  51. 8.9.2 Abbott Business Overview
  52. 8.9.3 Abbott Women's Health Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abbott Women's Health Product Portfolio
  54. 8.9.5 Abbott Recent Developments
  55. 8.10 Theramex
  56. 8.10.1 Theramex Company Information
  57. 8.10.2 Theramex Business Overview
  58. 8.10.3 Theramex Women's Health Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Theramex Women's Health Product Portfolio
  60. 8.10.5 Theramex Recent Developments
  61. 8.11 Livzon Pharmaceutical Group
  62. 8.11.1 Livzon Pharmaceutical Group Company Information
  63. 8.11.2 Livzon Pharmaceutical Group Business Overview
  64. 8.11.3 Livzon Pharmaceutical Group Women's Health Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Livzon Pharmaceutical Group Women's Health Product Portfolio
  66. 8.11.5 Livzon Pharmaceutical Group Recent Developments
  67. 8.12 Foundation Consumer Healthcare
  68. 8.12.1 Foundation Consumer Healthcare Company Information
  69. 8.12.2 Foundation Consumer Healthcare Business Overview
  70. 8.12.3 Foundation Consumer Healthcare Women's Health Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Foundation Consumer Healthcare Women's Health Product Portfolio
  72. 8.12.5 Foundation Consumer Healthcare Recent Developments
  73. 8.13 Zhejiang Xianju Pharmaceutical
  74. 8.13.1 Zhejiang Xianju Pharmaceutical Company Information
  75. 8.13.2 Zhejiang Xianju Pharmaceutical Business Overview
  76. 8.13.3 Zhejiang Xianju Pharmaceutical Women's Health Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zhejiang Xianju Pharmaceutical Women's Health Product Portfolio
  78. 8.13.5 Zhejiang Xianju Pharmaceutical Recent Developments
  79. 8.14 Zizhu Pharmaceutical
  80. 8.14.1 Zizhu Pharmaceutical Company Information
  81. 8.14.2 Zizhu Pharmaceutical Business Overview
  82. 8.14.3 Zizhu Pharmaceutical Women's Health Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zizhu Pharmaceutical Women's Health Product Portfolio
  84. 8.14.5 Zizhu Pharmaceutical Recent Developments
  85. 8.15 Qianjin Pharmaceutical
  86. 8.15.1 Qianjin Pharmaceutical Company Information
  87. 8.15.2 Qianjin Pharmaceutical Business Overview
  88. 8.15.3 Qianjin Pharmaceutical Women's Health Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Qianjin Pharmaceutical Women's Health Product Portfolio
  90. 8.15.5 Qianjin Pharmaceutical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst